EXCHANGE TRADED CONCEPTS, LLCEXCHANGE TRADED CONCEPTS, LLC

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings1,036 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
XLYXLY
ETF

CONSUMER DISCRETIONARY SELT

809,139$136M5.1%$77.41+3.63%
2 qtrssince 2020-Q4
Increased
64
LQDLQD
ETF

ISHARES IBOXX INVESTMENT GRA

844,086$109.8M4.1%$111.42-5.11%
2 qtrssince 2020-Q4
Increased
59
HYGHYG
ETF

ISHR IBX USD HIYLD CB ETF-UI

1.2M$107.1M4.0%$65.78+1.08%
3 qtrssince 2020-Q3
Increased
59
VOEVOE
ETF

VANGUARD MID-CAP VALUE ETF

763,203$102.9M3.9%$107.78+13.28%
2 qtrssince 2020-Q4
Increased
62
TLTTLT
ETF

ISHARES 20 PLUS YEAR TREASURY BD

747,583$101.3M3.8%$130.14-13.12%
2 qtrssince 2020-Q4
Increased
59
XLIXLI
ETF

INDUSTRIAL SELECT SECT SPDR

1M$100.4M3.8%$82.87+10.75%
2 qtrssince 2020-Q4
Increased
62
PFFPFF
Preferred

ISHARES PREFERRED & INCOME S

2.6M$98.9M3.7%$27.93+0.49%
2 qtrssince 2020-Q4
Increased
57
IYRIYR
ETF

ISHARES US REAL ESTATE ETF

1.1M$98.7M3.7%$75.28+8.24%
2 qtrssince 2020-Q4
Increased
62
QQQQQQ
Unit

INVESCO QQQ TRUST SERIES 1 CL USD INC

290,071$92.6M3.5%$271.89+12.33%
3 qtrssince 2020-Q3
Increased
62
XLKXLK
ETF

TECHNOLOGY SELECT SECTOR FUND SPDR

506,081$67.2M2.5%$62.47+0.84%
2 qtrssince 2020-Q4
Increased
54
XLVXLV
ETF

HEALTH CARE SELECT SECTOR SPDR

564,899$65.9M2.5%$101.75+6.09%
3 qtrssince 2020-Q3
Increased
55
SDYSDY
ETF

SPDR S&P DIVIDEND ETF ETF

339,166$40M1.5%$92.82+13.50%
2 qtrssince 2020-Q4
Decreased
0
XLUXLU
ETF

UTILITIES SELECT SECTOR SPDR

580,496$37.2M1.4%$26.53+3.66%
2 qtrssince 2020-Q4
Decreased
0
XLPXLP
ETF

CONSUMER STAPLES SPDR

531,542$36.3M1.4%$58.73+2.88%
2 qtrssince 2020-Q4
Decreased
0
PGFPGF
Preferred

INVESCO EXCHANGE TRADED FD T

1.8M$34.8M1.3%$14.34-0.50%
3 qtrssince 2020-Q3
Decreased
0
IWSIWS
ETF

ISHARES RUSSELL MIDCAP VALUE INDEX FUND

308,320$33.7M1.3%$90.97+11.28%
2 qtrssince 2020-Q4
Increased
55
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

76,780$30.4M1.1%$319.76+15.61%
6 qtrssince 2019-Q4
Increased
64
VUGVUG
ETF

VANGUARD GROWTH ETF

117,207$30.1M1.1%$41.09+1.32%
2 qtrssince 2020-Q4
Increased
55

CAMECO CORP

1.7M$27.8M1.0%$15.03+9.15%
6 qtrssince 2019-Q4
Increased
73

DRAFTKINGS INC

378,124$23.2M0.9%$48.71+25.24%
4 qtrssince 2020-Q2
Increased
63
$2.7B
AUM
1,036
Positions
Q1 2021
Filing
Rating · 3.5
Quarterly Portfolio Change
-61%Q1'20$184.9M+226%Q2'20$602.9M+193%Q3'20$1.8B+22%Q4'20$2.2B+24%Q1'21$2.7B
Activity profile
$ moved · Q1'21
New15%Increased65%Decreased12%Exited8%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.9 quarters
<1Q15%1-4Q44%1-2Y40%2Y+0%

EXCHANGE TRADED CONCEPTS, LLC manages $2.7B across 1036 positions as of Q1 2021. Top holdings: XLY (5.1%), LQD (4.1%), HYG (4.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.

Q1 2021 Summary

Active quarter - 227 new positions, 181 exits, 555 increased. Top move: CCJ (INCREASED, conviction 73). Portfolio: $2.7B across 1036 positions.

Top holdings by portfolio weight

Total AUM$3B
XLY5.09%
LQD4.11%
HYG4.01%
VOE3.85%
TLT3.79%
XLI3.75%
PFF3.70%
IYR3.69%
QQQ3.46%
XLK2.51%
Other2.47%

Portfolio allocation by GICS sector

Sectors11
Unknown55.59%
Healthcare9.41%
Consumer Cyclical8.50%
Technology5.22%
Consumer Defensive4.63%
Financial Services3.98%
Communication Services3.95%
Energy2.87%
Real Estate2.38%
Industrials2.20%
Other1.29%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record59
Conviction43
Concentration44
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AMNAMNAMN HEALTHCARE SVCS INC
Q3 2024 Q2 2026+39,638 shares+$1.2M
8Q
ELVELVANTHEM INC
Q3 2024 Q2 2026+109,659 shares+$42.2M
8Q
ATRATRAPTARGROUP INC
Q3 2024 Q2 2026+6,619 shares+$757,080
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used